Goldman Sachs has been hired by Shire as the London-listed drug maker confronts a takeover offer, as explained in the Financial Times morning briefing. Shire turned down a $46 billion bid from Chicago-based AbbVie last week. According to a report from the New-York Times, people briefed on the matter said AbbVie was likely to come…
Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings…
AbbVie, Inc. (NYSE:ABBV) announced the initiation of a pivotal Phase 3 clinical trial that will evaluate the use of HUMIRA (adalimumab) as a treatment for fingernail psoriasis in patients with moderate to severe chronic plaque psoriasis, an area of unmet need. Currently there are no approved treatments for fingernail psoriasis. AbbVie Inc (NYSE:ABBV) stock performance…
